Evelo Biosciences Sees Unusually Large Options Volume
| EVLODelisted Stock | USD 8.23 2.68 24.56% |
About 61% of Evelo Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Evelo Biosciences pink sheet suggests that many investors are alarmed at this time. Evelo Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Evelo Biosciences. Many technical investors use Evelo Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Evelo |
Evelo Biosciences, Inc. saw unusually large options trading activity on Wednesday. Stock traders purchased 1,885 put options on the stock. This is an increase of 1,101 percent compared to the average daily volume of 157 put options. Insider Buying and Selling In other news, insider Mark Bodmer sold 3,128 shares of
Read at thelincolnianonline.com
 |
Evelo Biosciences Fundamental Analysis
We analyze Evelo Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evelo Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evelo Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Evelo Biosciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Evelo Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evelo Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics with similar companies.
Peers
Evelo Biosciences Related Equities
| ENSC | Ensysce Biosciences | 14.58 | ||||
| WINT | Windtree Therapeutics | 12.00 | ||||
| CTMX | CytomX Therapeutics | 6.25 | ||||
| PCSA | Processa Pharmaceuticals | 4.08 | ||||
| ALRN | Aileron Therapeutics | 4.07 | ||||
| NUVB | Nuvation Bio | 3.21 | ||||
| SRZN | Surrozen | 3.19 | ||||
| GBIO | Generation Bio | 2.86 | ||||
| ASMB | Assembly Biosciences | 2.63 | ||||
| TPST | Tempest Therapeutics | 2.17 | ||||
| ERAS | Erasca | 0.72 | ||||
| EWTX | Edgewise Therapeutics | 0.31 | ||||
| ABVC | ABVC Biopharma | 1.92 | ||||
| KRON | Kronos Bio | 2.25 | ||||
| TIL | Instil Bio | 2.83 | ||||
| CCCC | C4 Therapeutics | 4.34 | ||||
| DRMA | Dermata Therapeutics | 4.35 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |